Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31
Phase 45

Trial Status

Completed10

Role Distribution

Principal Investigator10
PI Rate100%

Activity Timeline

Clinical Trials (10)

NCT04885907Phase 4Completed
Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients
Covid19Immune SuppressionVaccine Response Impaired
PrincipalinvestigatorStart date: 2021-05-25
NCT03139565Phase 3Completed
High Dose vs. Standard Influenza Vaccine in Adult SOT
ImmunosuppressionInfluenza
PrincipalinvestigatorStart date: 2016-10-01
NCT02560909Phase 4Completed
Adjuvanted Influenza Vaccine in Stem Cell Transplant
Influenza VaccinesTransplantation
PrincipalinvestigatorStart date: 2015-10-01
NCT02370758Not ApplicableCompleted
Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients
Cytomegalovirus Viraemia
PrincipalinvestigatorStart date: 2014-11-01
NCT00402402Phase 4Completed
Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver Disease
Chronic Liver DiseaseLiver TransplantationTuberculosis
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT04885907Phase 4PrincipalInvestigator

Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients

Covid19Immune SuppressionVaccine Response Impaired
Completed
NCT03139565Phase 3PrincipalInvestigator

High Dose vs. Standard Influenza Vaccine in Adult SOT

ImmunosuppressionInfluenza
Completed
NCT02560909Phase 4PrincipalInvestigator

Adjuvanted Influenza Vaccine in Stem Cell Transplant

Influenza VaccinesTransplantation
Completed
NCT02370758Not ApplicablePrincipalInvestigator

Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients

Cytomegalovirus Viraemia
Completed
NCT00242099Phase 4PrincipalInvestigator

Clinical Utility of Monitoring for Human Herpesvirus-6 (HHV-6) and Human Herpesvirus-7 (HHV-7) After Liver Transplant

Transplant
Completed
NCT00402402Phase 4PrincipalInvestigator

Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver Disease

Chronic Liver DiseaseLiver TransplantationTuberculosis
Completed
NCT00402805Phase 4PrincipalInvestigator

Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy

Influenza VaccinesLung Transplantation
Completed
NCT00436384PrincipalInvestigator

Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients

Transplant
Completed
NCT01584908PrincipalInvestigator

Adjuvanted Influenza Vaccine Evaluation in Kidney Transplant Recipients

Influenza
Completed
NCT02784756Not ApplicablePrincipalInvestigator

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients

Cytomegalovirus Viraemia
Completed

All 10 trials loaded